Lipid analysis of tear fluid as a diagnostic tool for meibomian gland dysfunction
DOI: 10.32364/2311-7729-2024-24-2-7
L.R. Takhauova1,2, A.A. Guseva1, A.A. Krylova1, O.I. Krivosheina1
1Siberian State Medical University, Tomsk, Russian Federation
2Seversk Biophysical Scientific Center of the Federal Medical Biological Agency of Russia, Seversk, Russian Federation
The tear film lipid layer plays a crucial role in maintaining ocular surface homeostasis by preventing excessive evaporation of the aqueous layer and reducing heat transfer from the corneal and conjunctival surface. The lipid composition of the tear film is unique and consists of two main layers: the outer (nonpolar lipids) and the inner (polar lipids). The thick outer layer of the tear film is composed of non-polar lipids that lack internal distributed charge, while the thin inner layer is formed by polar lipids with positive and negative charges at the ends of the molecule. Both types of lipids are synthesized in the meibomian glands (MG) and contribute to tear film stability. Meibomian gland dysfunction (MGD) alters the composition and physical properties of lipids, leading to pathological changes in both the MG and tear film. In meibomian gland dysfunction (MGD), the meibum thickens and acquires a higher melting point than normal. This leads to a decrease in the amount of nonpolar and amphiphilic lipids in the meibomian gland secretion and tear film. Consequently, the protective effect of the tear lipid layer is impaired, and its stability is compromised.
Lipid mapping analyzes the lipid composition of biological samples, such as tear fluid, to study the mechanisms of the development and progression of various ocular surface diseases, including dry eye syndrome, MGD, and recurrent blepharoconjunctivitis. This method provides fundamental data on the properties of the tear film in various ocular surface diseases. It has the potential to establish hallmarks of disease course and develop personalized treatment approaches for specific clinical cases.
Keywords: tear, tear film lipids, ocular surface, meibomian gland dysfunction, lipid analysis.
For citation: Takhauova L.R., Guseva A.A., Krylova A.A., Krivosheina O.I. Lipid analysis of tear fluid as a diagnostic tool for meibomian gland dysfunction. Russian Journal of Clinical Ophthalmology. 2024;24(2):83–87 (in Russ.). DOI: 10.32364/2311-7729-2024-24-2-7.
About the authors:
Liliya R. Takhauova — postgraduate student of the Department of Ophthalmology, Siberian State Medical University; 2, Moskovskiy tract, Tomsk, 634050, Russian Federation; junior researcher, Seversk Biophysical Scientific Center of the Federal Medical Biological Agency of Russia; 7, build. 2, Chekist lane, Seversk, 634013, Russian Federation; ORCID iD 0000-0002-6261-9795.
Alina A. Guseva — resident of the Department of Ophthalmology, Siberian State Medical University; 2, Moskovskiy tract, Tomsk, 634050, Russian Federation; ORCID iD 0009-0009-9832-1710.
Anna A. Krylova — C. Sc. (Med.), associate professor of the Department of Ophthalmology, Siberian State Medical University; 2, Moskovskiy tract, Tomsk, 634050, Russian Federation; ORCID iD 0000-0001-8009-6302.
Olga I. Krivosheina — Dr. Sc. (Med.), Professor, Head of the Department of Ophthalmology, Siberian State Medical University; 2, Moskovskiy tract, Tomsk, 634050, Russian Federation; ORCID iD 0000-0001-7509-5858.
Contact information: Lilliya R. Takhauova, e-mail: tahauovaa@gmail.com.
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 05.02.2024.
Revised 29.02.2024.
Accepted 27.03.2024.
2. Craig J.P., Nelson J.D., Azar D.T. TFOS DEWS II Report Executive Summary. Ocul Surf. 2017;XXX:1–11. DOI: 10.1016/j.jtos.2017.08.003.
3. Gipson I.K. Distribution of mucins at the ocular surface. Exp Eye Res. 2004;78(3):379–388. DOI: 10.1016/s0014-4835(03)00204-5.
4. Бржеский В.В. Синдром «сухого глаза» у людей молодого возраста: нерешенная проблема современности. Современная оптометрия. 2007;2(2):38–43.Brzheskij V.V. Dry eye syndrome in young people: unsolved problem of the modern time. Modern optometry. 2007;2(2):38–43 (in Russ.).
5. Сафонова Т.Н., Медведева Е.С. Дисфункция мейбомиевых желез у пациентов с сахарным диабетом. Сахарный диабет. 2022;25(2):186–191. DOI: 10.14341/DM12798.Safonova T.N., Medvedeva E.S. Dysfunction of the meibomian glands in patients with diabetes mellitus. Diabetes mellitus. 2022;25(2):186–191 (in Russ.). DOI: 10.14341/DM12798.
6. Сафонова Т.Н., Атькова Е.Л., Кинтюхина Н.П., Резникова Л.В. Современные методы исследования морфофункционального состояния век при дисфункции мейбомиевых желез. Вестник офтальмологии. 2018;134(5):276–281. DOI: 10.17116/oftalma2018134051276.Safonova T.N., At'kova E.L., Kintukhina N.P., Reznikova L.V. Modern methods of evaluating the morphological and functional state of the eyelids in chronic blepharitis. Vestnik Oftalmologii. 2018;134(5):276–281 (in Russ.). DOI: 10.17116/oftalma2018134051276.
7. Бржеский В.В., Егорова Г.Б., Егоров Е.А. Синдром «сухого глаза» и заболевания глазной поверхности: клиника, диагностика, лечение. М.: ГЭОТАР-Медиа. 2016:464. Brzheskij V.V., Egorova G.B., Egorov E.A. Dry eye syndrome and diseases of the eye surface: clinical course, diagnostics, treatment. M.: GEOTAR-Media. 2016:464 (in Russ.).
8. Oxholm P., Daniels T., Bendtzen K. Cytokine expression in labial salivary glands from patients with primary Sjogrens syndrome. Autoimmunity. 1992;12(3):185–191. DOI: 10.3109/08916939209148458.
9. Бржеский В.В. Синдром «сухого глаза» — болезнь цивилизации: современные возможности диагностики и лечения. Медицинский Совет. 2013;(3):114–116. DOI: 10.21518/2079-701X-2013-3-114-116.Brzhesky V.V. Dry eye syndrome: a disease of the civilization. diagnosis and treatment options. Medical Council. 2013;(3):114–116 (in Russ.). DOI: 10.21518/2079-701X-2013-3-114-116.
10. Elgin C.Y., Iskeleli G., Aydin O. Effects of the rigid gas permeable contact lense use on tear and ocular surface among keratoconus patients. Cont Lens Anterior Eye. 2018;41(3):273–276. DOI: 10.1016/j.clae.2017.12.013.
11. Аветисов С.Э., Сурнина З.В., Новиков И.А. и др. Влияние слезной пленки на результаты прямой оценки чувствительности роговицы. Вестник офтальмологии. 2020;136(2):81–85. DOI: 10.17116/oftalma202013602181.Avetisov S.É., Surnina Z.V., Novikov I.A. et al. The effect of the tear film on the results of a direct assessment of the sensitivity of the cornea. Vestnik Oftalmologii. 2020;136(2):81–85 (in Russ.). DOI: 10.17116/oftalma202013602181.
12. Сафонова Т.Н., Медведева Е.С. Современные возможности исследования состава секрета мейбомиевых желез. Вестник офтальмологии. 2022;138(1):84–89. DOI: 10.17116/oftalma202213801184.Safonova T.N., Medvedeva E.S. Modern possibilities of studying the composition of meibomian glands secretion. Vestnik Oftalmologii. 2022;138(1):84–89 (in Russ.). DOI: 10.17116/oftalma202213801184.
13. Oxholm P., Daniels T., Bendtzen K. Cytokine expression in labial salivary glands from patients with primary Sjogrens syndrome. Autoimmunity. 1992;12(3):185–191. DOI: 10.3109/08916939209148458.
14. Jones D.T., Monroy D., Ji Z. et al. Sjögren's syndrome: cytokine and Epstein-Barr viral gene expression within the conjunctival epithelium. Invest Ophthalmol Vis Sci. 1994;35(9):3493–3504. PMID: 8056525.
15. Мошетова Л.К., Косырев А.Б., Цихончук Т.В., Яровая Г.А. Оценка региональной фибринолитической активности слезной жидкости путем определения уровня D-димера у пациентов с окклюзией ретинальных вен. Офтальмологические ведомости. 2016;9(4):18–29. DOI: 10.17816/OV9418-29. Moshetova L.K, Kosyrev A.B., Tsikhonchuk T.V., Yarovaya G.A. assessment of regional fibrinolytic activity of tear fluid by determining the levels of D-dimer in patients with retinal vein occlusion. Ophthalmology Journal. 2016;9(4):18–29 (in Russ.). DOI: 10.17816/OV9418-29.
16. McDonald J.E. Surface phenomena of the tear film. Am J Ophthalmol. 1969;67(1):56–64. DOI: 10.1016/0002-9394(69)90008-7.
17. Fang L., Liu J., Liu Z. Immune modulating nanoparticles for the treatment of ocular diseases. J Nanobiotechnology. 2022;20(1):496. DOI: 10.1186/s12951-022-01658-5.
18. Butovich I.A., Wojtowicz J.C., Molai M. Human tear film and meibum. Very long chain wax esters and (O-acyl)-omega-hydroxy fatty acids of meibum. J Lipid Res. 2009;50(12):2471–2485. DOI: 10.1194/jlr.M900252-JLR200.
19. Butovich I.A. Tear film lipids. Exp Eye Res. 2013;117:4–27. DOI: 10.1016/j.exer.2013.05.010.
20. Cwiklik L. Tear film lipid layer: A molecular level view. Biochim Biophys Acta. 2016;1858(10):2421–2430. DOI: 10.1016/j.bbamem.2016.02.020.
21. Butovich I.A. On the presence and role of polar lipids in meibum. Invest Ophthalmol Vis Sci. 2010;51(12):6908–6911. DOI: 10.1167/iovs.10-6328.
22. Nicolaides N., Kaitaranta J.K., Rawdah T.N. et al. Meibomian gland studies: comparison of steer and human lipids. Invest Ophthalmol Vis Sci. 1981;20(4):522–536. PMID: 7194326.
23. Lam S.M., Tong L., Duan X. et al. Longitudinal changes in tear fluid lipidome brought about by eyelid-warming treatment in a cohort of meibomian gland dysfunction. J Lipid Res. 2014;55(9):1959–1969. DOI: 10.1194/jlr.P051185.
24. Arita R., Mori N., Shirakawa R. et al. Meibum Color and Free Fatty Acid Composition in Patients With Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2015;56(8):4403–4412. DOI: 10.1167/iovs.14-16254.
25. Driver P.J., Lemp M.A. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40(5):343–367. DOI: 10.1016/s0039-6257(96)80064-6.
26. Yokoi N., Georgiev G.A. Tear-film-oriented diagnosis for dry eye. Jpn J Ophthalmol. 2019;63:127–136. DOI: 10.1007/s10384-018-00645-4.
27. Garrigue J.-S., Amrane M., Faure M.-O. Relevance of Lipid-Based Products in the Management of Dry Eye Disease. J Ocul Pharmacol Ther. 2017;33(9):647661. DOI: 10.1089/jop.2017.0052.
28. Uysal B.S., Akcay E., Kilicarslan A. et al. Tear function and ocular surface changes following corneal collagen cross-linking treatment in keratoconus patients: 18-month results. Int Ophthalmol. 2020;40(1):169–177. DOI: 10.1007/s10792-019-01161-1.
29. Doughty M.J. Goblet cell density estimate differences in impression cytology samples varies with different magnification of images. Cont Lens Anterior Eye. 2018;41(3):290–296. DOI: 10.1016/j.clae.2017.12.002.
30. McCulley J.P., Shine W.E. Meibomian secretions in chronic blepharitis. Adv Exp Med Biol. 1998;438:319–326. DOI: 10.1007/978-1-4615-5359-5_45.
31. Qazi Y., Kheirkhah A., Blackie C. et al. Clinically Relevant Immune-Cellular Metrics of Inflammation in Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2018;59:6111–6123. DOI: 10.1167/iovs.18-25571.
32. Borchman D., Ramasubramanian A., Foulks G.N. Human Meibum Cholesteryl and Wax Ester Variability With Age, Sex, and Meibomian Gland Dysfunction. Invest Ophthalmol Vis Sci. 2019;60(6):2286–2293. DOI: 10.1167/iovs.19-26812.
33. Borchman D. The optimum temperature for the heat therapy for meibomian gland dysfunction. Ocul Surf. 2019;17(2):360–364. DOI: 10.1016/j.jtos.2019.02.005.
34. Pucker A.D., Haworth K.M. The presence and significance of polar meibum and tear lipids. Ocul Surf. 2015;13(1):26–42. DOI: 10.1016/j.jtos.2014.06.002.
35. Runzhong F., Klinngam W., Heur M. et al. Tear proteases and protease inhibitors: potential biomarkers and disease drivers in ocular surface disease. Eye Contact Lens. 2021;46(2):70–83. DOI: 10.1097/ICL.0000000000000641.
36. Minami M., Otake H., Nakazawa Y. et al. Balance of Drug Residence and Diffusion in Lacrimal Fluid Determine Ocular Bioavailability in In Situ Gels Incorporating Tranilast Nanoparticles. Pharmaceutics. 2021;13(9):1425. DOI: 10.3390/pharmaceutics13091425.
37. Siddireddy J.S., Vijay A.K., Tan J., Willcox M. Effect of Eyelid Treatments on Bacterial Load and Lipase Activity in Relation to Contact Lens Discomfort. Eye Contact Lens. 2020;46(4):245–253. DOI: 10.1097/ICL.0000000000000673.
38. Ogawa Y., Shimizu E., Tsubota K. Interferons and Dry Eye in Sjögren's Syndrome. Int J Mol Sci. 2018;19(11):3548. DOI: 10.3390/ijms19113548.
39. Varu D.M., Rhee M.K., Akpek E.K. et al. Conjunctivitis Preferred Practice Pattern. Ophthalmology. 2019;126(1):P94–P169. DOI: 10.1016/j.ophtha.2018.10.020.
40. Tang Z., Fan X., Chen Y., Gu P. Ocular Nanomedicine. Adv Sci (Weinh). 2022;9(15):e2003699. DOI: 10.1002/advs.202003699.
41. Dammak A., Huete-Toral F., Carpena-Torres C. et al. From Oxidative Stress to Inflammation in the Posterior Ocular Diseases: Diagnosis and Treatment. Pharmaceutics. 2021;13(9):1376. DOI: 10.3390/pharmaceutics13091376.
42. Fan R., Chan T.C., Prakash G., Jhanji V. Applications of corneal topography and tomography: A review. Clin Exp Ophthalmol. 2018;46:133–146. DOI: 10.1111/ceo.13136.
43. Zhang X.H., Li X. Effect of rigid gas permeable contact lens on keratoconus progression: a review. Int J Ophthalmol. 2020;13(7):1124–1131. DOI: 10.18240/ijo.2020.07.17.
44. Doughty M.J. Consideration of three types of spontaneous eyeblink activity in normal humans: during reading and video display terminal use, in primary gaze, and while in conversation. Optom Vis Sci. 2001;78(10):712–725. DOI: 10.1097/00006324-200110000-00011.
45. Yilmaz F.O., Yildiz B.K., Tunc U. et al. Comparison of topical omega-3 fatty acids with topical sodium hyaluronate after corneal crosslinking: Short-term results. Ocul Immunol Inflamm. 2021;9:1–7. DOI: 10.1080/09273948.2020.1858117.
46. Wang L., Luo S., Xu H. et al. Evaluation of His-Metal Assemblies as a Drug Delivery Vehicle in the Treatment of Anterior Segment Disease Using a Corneal Inflammation Model. ACS Biomater Sci Eng. 2020;6:4012–4023. DOI: 10.1021/acsbiomaterials.0c00218.
47. Ung L., Bispo P.J.M., Shanbhag S.S. et al. The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance. Surv Ophthalmol. 2019;64:255–271. DOI: 10.1016/j.survophthal.2018.12.003.
48. Ситник Г.В., Камышников В.С., Лебедева П.А. Лабораторное исследование слезной жидкости на основе использования стандартизованной технологии ее забора и пробоподготовки: результаты валидации способа взятия биологической жидкости. Лабораторная диагностика. Восточная Европа. 2021;10(4):483–492. DOI: 10.34883/PI.2021.10.4.009.Sitnik H.V., Kanishnikov V.S., Lebedeva P.A. Laboratory Study of Tear Fluid Based on the Use of a Standardized Technology for Its Collection and Sample Preparation: Results of Validation of the Method for Taking Biological Fluid. Laboratory diagnostics. Eastern Europe. 2021;10(4):483–492 (in Russ.). DOI: 10.34883/PI.2021.10.4.009.
49. Niu L., Liu X., Ma Z. et al. Fungal keratitis: Pathogenesis, diagnosis and prevention. Microb Pathog. 2020;138:103802. DOI: 10.1016/j.micpath.2019.103802.
This work is licensed under a Creative Commons «Attribution» 4.0 License.
